Ads
related to: drugs approved for bladder cancer treatment- Financial Support
Find Info On Financial Support
For Eligible Patients. Learn More.
- FAQs
Find FAQs For This Treatment Option
On The Official Patient Site.
- Safety Information
Important Safety Info And More
On The Official Patient Site.
- Resources & Support
For Patient And Caregiver
Learn More.
- Financial Support
Search results
Results from the WOW.Com Content Network
The antibody treatment, sasanlimab, in combination with Bacillus Calmette-Guérin (BCG) vaccine met the main goal of the study in patients with high-risk non-muscle invasive bladder cancer (NMIBC ...
In April 2019, erdafitinib was granted approval by the US Food and Drug Administration (FDA) for treatment of metastatic or locally advanced bladder cancer with an FGFR3 or FGFR2 alteration that has progressed beyond traditional platinum-based therapies, subject to a confirmatory trial.
The drug is used in combination with the Bacillus Calmette-Guérin (BCG) vaccine, which is mainly used against tuberculosis, but also as a common treatment for some forms of bladder cancer.
Nogapendekin alfa inbakicept, sold under the brand name Anktiva, is a fixed-dose combination medication used for the treatment of bladder cancer. [1] It is an interleukin-15 receptor agonist. [1] It is given in combination with Bacillus Calmette-Guérin via intravesical drug delivery. [1]
Medicare covers treatment and services for bladder cancer; however, you may still have significant out-of-pocket costs depending on factors like recommended treatment or the stage of your cancer.
Gemcitabine, sold under the brand name Gemzar, among others, [1] is a chemotherapy medication used to treat cancers. [2] It is used to treat testicular cancer, [3] breast cancer, ovarian cancer, non-small cell lung cancer, pancreatic cancer, and bladder cancer. [2] [4] It is administered by intravenous infusion. [2]
Ads
related to: drugs approved for bladder cancer treatment